Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
36.11 0.91(2.46%) Jul 28, 3:59PM EDT
ProfileGet Profile for:
Myriad Genetics Inc.
320 Wakara Way
Salt Lake City, UT 84108
United States - Map
Phone: 801-584-3600
Fax: 801-584-3640
Website: http://www.myriad.com

Details 
Index Membership:N/A
Sector:Services
Industry:Research Services
Full Time Employees:1,325

Business Summary 

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. The company’s molecular diagnostic tests are designed to analyze genes, their mutations, expression levels, and proteins to assess an individual’s risk for developing disease later in life; determine a patient’s likelihood of responding to a particular drug; and assess a patient’s risk of disease progression and disease recurrence. It offers various molecular diagnostic tests that include BRACAnalysis and BART, which are predictive medicine tests for hereditary breast and ovarian cancer; COLARIS predictive medicine test for hereditary colorectal and uterine cancer; COLARIS AP predictive medicine test for hereditary colorectal cancer; MELARIS predictive medicine test for hereditary melanoma; PANEXIA, a predictive medicine test for pancreatic cancer; PREZEON, a personalized and prognostic medicine test for cancer; Prolaris, a prognostic medicine test for prostate cancer; and TheraGuide 5-FU, a personalized medicine test for drug toxicity. The company, through its subsidiary, Myriad RBM, Inc., also offers biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical research industries that include multi-analyte profile testing services; multiplexed immunoassay kits; and TruCulture, a self-contained whole blood culture that allows pharmaceutical and biotechnology companies to identify drug toxicity prior to human trials. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.

Key Statistics


Company Websites 
Home Page
Investor Relations
Employment
Search Yahoo! for:
More on Myriad Genetics Inc.

Corporate Governance 
Myriad Genetics Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 9. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 7; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Dr. Peter D. Meldrum Ph.D., 67
Chief Exec. Officer, Pres and Director
2.21M5.77M
Dr. Walter A. Gilbert Ph.D., 82
Founding Scientist, Vice Chairman and Member of Compensation Committee
67.00KN/A
Mr. James S. Evans , 51
Chief Financial Officer, Principal Accounting Officer and Treasurer
796.00K2.33M
Dr. Jerry S. Lanchbury Ph.D., 55
Chief Scientific Officer
713.00K2.16M
Mr. Richard M. Marsh Esq., 56
Exec. VP, Gen. Counsel and Sec.
727.00K2.83M
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders